How Insurance Reimbursement Actually Works

Healthcare reimbursement is not a pricing system in any conventional sense. It is a multi-party negotiation conducted in code — literally. Every clinical service delivered in the United States is translated into a standardized billing language before any money moves. The two dominant code sets are CPT codes, which describe procedures and clinical services, and ICD codes, which describe diagnoses. A CPT code without a supporting ICD code is almost always a denied claim. Understanding this pairing is the entry point to understanding why healthcare billing is its own profession.

CPT codes — Current Procedural Terminology — are maintained by the American Medical Association and are the primary language providers use to bill payers. Each code maps to a specific clinical action: an office visit, a surgical procedure, a laboratory test, a therapy session. The code does not tell you what anyone will get paid. It tells you what service was performed. What the payer reimburses for that code depends entirely on the contract between the provider and the payer, and those contracts are private, vary enormously, and are negotiated in ways that are opaque even to most people inside the system.

Medicare sets the baseline that the rest of the system negotiates around. The Centers for Medicare and Medicaid Services, known as CMS, publishes a fee schedule — the Medicare Physician Fee Schedule — that assigns a relative value unit, or RVU, to every CPT code. RVUs measure three things: physician work, practice expense, and malpractice expense. CMS converts RVUs into dollar amounts annually using a dollar-per-RVU conversion factor. When private insurers negotiate rates, they almost always anchor to a percentage of Medicare rates — typically 110% to 140% of Medicare for in-network providers, though the range is wide.

Medicare itself is not a single program. Part A covers inpatient hospital care. Part B covers outpatient services and physician fees — this is where CPT codes and the physician fee schedule live. Part C is Medicare Advantage, where private insurers administer Medicare benefits under contract with CMS and can modify coverage and network terms within regulatory guardrails. Part D covers prescription drugs. A product or service that gets covered under Medicare Part B follows a completely different regulatory and reimbursement path than one covered under Part D. New entrants consistently conflate these, which produces business plans built on reimbursement assumptions that do not apply to their category.

New technologies and services face an additional problem: they may not have a CPT code at all, or they may have a temporary code that payers are not obligated to reimburse. The AMA Category III CPT codes are temporary tracking codes assigned to emerging technologies. They allow billing to occur but do not guarantee payment. Getting a permanent Category I CPT code requires demonstrated clinical adoption and a formal AMA application process that takes years. Many digital health and medical device companies discover this problem after their product is built, which is why reimbursement strategy must begin at the product concept stage.

Prior authorization is the mechanism payers use to review clinical necessity before a service is delivered or reimbursed. It is both a cost control tool and a friction mechanism. Some payers require prior auth for high-cost procedures, specialty medications, and certain diagnostics. The prior authorization burden falls primarily on the provider, not the patient or the technology vendor — but if your product requires provider staff to initiate and manage prior auth requests, that administrative cost is a real barrier to adoption that your sales model must account for.

The chargemaster — the official list price a hospital assigns to every service — is a number almost nobody pays. It is the starting point for negotiation, not the transaction price. Insurers negotiate contracted rates that are often 30% to 70% below chargemaster. Uninsured patients are often billed at chargemaster initially, then discounted under charity care policies. Medicare and Medicaid pay at statutorily set rates regardless of chargemaster. The chargemaster matters for understanding healthcare pricing dynamics, but it is a poor proxy for understanding what any given payer will actually reimburse.